XLV - Health Care Select Sector SPDR ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
83.02
-0.37 (-0.44%)
As of 12:30PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close83.39
Open83.34
Bid0.00 x 2200
Ask0.00 x 3000
Day's Range82.69 - 83.48
52 Week Range75.65 - 91.79
Volume3,351,816
Avg. Volume8,248,691
Net Assets15.28B
NAV82.22
PE Ratio (TTM)N/A
Yield1.51%
YTD Return-0.16%
Beta (3y)0.96
Expense Ratio (net)0.14%
Inception Date1998-12-16
Trade prices are not sourced from all markets
  • Analyzing Tepper’s Top Investment Sectors
    Market Realist5 hours ago

    Analyzing Tepper’s Top Investment Sectors

    Previously, we discussed billionaire investor David Tepper’s largest holdings and top buys and sells in the first quarter. In this part, we’ll look at Tepper’s top investment sectors based on his Appaloosa Management holdings.

  • Investopedia6 days ago

    Why J&J's Stock May Plunge 10%

    Johnson & Johnson ( JNJ) shares may drop by about 10% based on an analysis of the technical chart. Should shares of the stock fall an additional 10%, it would mean Johnson and Johnson would have dropped by nearly 25% from its intraday high of around $148 on January 22. The technical setup continues to be negative in the stock, and it appears shares could fall from roughly $124.25 to about $111.33, a drop of 10.4%.

  • MarketWatch10 days ago

    President Trump’s big drug price speech boosts pharma stocks

    After weeks of build-up, drug industry watchers began to have real concerns about President Donald Trump’s big drug price speech on Friday. Many of the changes that were mentioned on Friday had been raised before by his administration, including drug price negotiation for certain government programs. Other proposals seemed unlikely to significantly bring down drug prices in the near-term, which Trump described as a goal of the plan.

  • ETF Trends13 days ago

    6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’

    Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to "global freeloading" that has allowed foreign countries to pay less on American-manufactured medicines. The Health Care Select Sector SPDR (XLV), the largest healthcare exchange traded fund, gained 1.5% Friday while the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB) , the largest biotech exchange traded fund by assets, rose 2.7% and VanEck Vectors Generic Drugs ETF (GNRX) , which focuses on generic drug producers, added 2.2%.

  • Trump lets drug companies off the hook
    Yahoo Finance13 days ago

    Trump lets drug companies off the hook

    After several delays, President Trump unveiled a plan to lower drug prices. Don't bank on it just yet.

  • MarketWatch13 days ago

    Drug stocks slip, then swing back even higher after Trump unveils drug cost cutting plan

    Healthcare stocks dipped after President Donald Trump started presenting his plan to cut prescription drug costs, then bounced sharply to trade even higher than pre-speech levels. The SPDR Health Care Select Sector ETF was up about 0.5% before Trump's speech began, then slid to be down 0.1% swinging higher to be up 1.1% at a new intraday high. Some changes to policy announced by Trump and Health and Human Services Secretary Alex Azar included drug price negotiation by government programs, an end to the "gag rule" on pharmacists--who cannot disclose if drug products can be bought for cheaper without using a health plan -- and disclosure of drugs' list prices pharmaceutical advertisements.

  • Benzinga13 days ago

    Trump Strikes At PBMs, Insurers, Drugmakers With Plans To Lower Consumer Prices

    Stocks representing the U.S. drug supply chain temporarily tumbled Friday as President Donald Trump proposed a broad plan to lower consumer health costs. Last year, it increased federal lobbying spending by 30 percent, and it may maintain such investments to prevent future follow-through.

  • What Were the Hiring and Firing Trends in March?
    Market Realist14 days ago

    What Were the Hiring and Firing Trends in March?

    The “Job Openings and Labor Turnover Survey” (or JOLTS) data for March was reported on May 8 and contains key information about job openings and total separations. The total number of separations include layoffs, retirements, and voluntary quits. As per the latest JOLTS report, the total separations for March came in at 5.3 million at a rate of 3.6% of the total workforce, an increase from the February reading of 5.2 million and 3.5%, respectively.

  • FDA Approves JNJ’s Darzalex in Combination with VMP
    Market Realist16 days ago

    FDA Approves JNJ’s Darzalex in Combination with VMP

    Johnson & Johnson’s (JNJ) Darzalex injection is a CD-38 surface protein–directed antibody approved for the treatment of multiple myeloma. Today, JNJ announced that the US Food & Drug Administration (or FDA) approved Darzalex in combination with other drugs for the treatment of multiple myeloma, marking the fifth indication for which Darzalex has FDA approval.

  • Analyzing Merck’s Revenue in 1Q18
    Market Realist16 days ago

    Analyzing Merck’s Revenue in 1Q18

    Merck (MRK), one of the largest pharmaceutical companies worldwide, is classified into four business segments: Human Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company reported its 1Q18 results on May 1. During the quarter, Merck surpassed analysts’ EPS (earnings per share) estimate of $1, but missed their revenue estimate of $10.1 billion, reporting EPS of $1.05 on revenue of $10.0 billion.

  • Which Sector Posted Major Job Gains in April?
    Market Realist21 days ago

    Which Sector Posted Major Job Gains in April?

    The ADP March employment report was published on May 2. The report offered deeper insight into employment trends across different sectors in the US employment market. ADP and Moody’s Analytics prepared the monthly report.

  • Mounting Evidence of Inflation Firming Up
    Market Realist22 days ago

    Mounting Evidence of Inflation Firming Up

    The U.S. Commerce Department reported retail sales fell in February for the third month in a row, while the University of Michigan Consumer Sentiment Index4 jumped to a 14-year high and the Conference Board Consumer Confidence Index5 hovers near 17-year highs. This suggests that while times are good for most people, they have little desire to spend more in an economic expansion that is one of the longest on record. Households may save their gains from the Trump tax cuts, rather than spend in the economy, as the Commerce Department reports the savings rate ticked higher in February.

  • Merck & Co.’s 1Q18 Earnings: Revenues up 6%
    Market Realist23 days ago

    Merck & Co.’s 1Q18 Earnings: Revenues up 6%

    Headquartered in New Jersey, Merck & Co. (MRK) is one of the largest pharmaceutical companies worldwide. Its business is classified into four business segments: Human Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck & Co. beat Wall Street analysts’ estimates for earnings per share (or EPS) today but missed analysts’ estimates for revenues. It reported EPS of $1.05 on revenues of $10.0 billion for 1Q18, compared to estimates of EPS of $1.00 on revenues of $10.1 billion.

  • Jim Chanos: ‘Winter Is Coming to the US Health Care System’
    Market Realist23 days ago

    Jim Chanos: ‘Winter Is Coming to the US Health Care System’

    Famed short seller Jim Chanos said in a recent interview, “winter is coming to the US health care system.” He has a bearish view on the healthcare sector and disclosed that he has a short position in Envision Healthcare (EVHC). EVHC stock price fell 2.2% on April 26 after Jim Chanos’s announcement about his short position in the stock.

  • ETF Trends24 days ago

    Healthcare ETFs Lag Markets as Celgene Drags

    Healthcare stocks and healthcare ETFs were among the worst performing areas of the S&P 500 Monday as Celgene (CELG) shares plunged in response to Morgan Stanley's projecting that a key experimental drug could be delayed. The Health Care Select Sector SPDR (XLV), the largest healthcare exchange traded fund, fell 0.7% Monday and was testing its short-term supporting trend line at the 50-day simple moving average. Additionally, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB) , the largest biotech exchange traded fund by assets, declined 1.1%.

  • Bristol-Myers Squibb’s 1Q18 Earnings Beat Wall Street Estimates
    Market Realist28 days ago

    Bristol-Myers Squibb’s 1Q18 Earnings Beat Wall Street Estimates

    Bristol-Myers Squibb (BMY) beat Wall Street analysts’ estimates for earnings per share (or EPS) and revenues in 1Q18. It reported EPS of $0.94 on revenues of $5.2 billion in 1Q18 today, compared to analysts’ estimates for EPS of $0.85 on revenues of $5.2 billion.

  • Another Indicator Signaling Rising Inflation
    Market Realistlast month

    Another Indicator Signaling Rising Inflation

    The US Bureau of Labor Statistics releases a monthly report that tracks price trends in wholesale markets. Industries from the manufacturing sector (XLI) are surveyed for changes in input prices, and this survey data is used to construct the PPI (Producer Price Index). The survey comprises questions on raw material prices, production levels, and finished goods.

  • 3.2 Million Americans Quit Their Jobs in February
    Market Realistlast month

    3.2 Million Americans Quit Their Jobs in February

    The “Job Openings and Labor Turnover Survey” (or JOLTS) data for February was reported on April 13, and it contains information about job openings and total separations. The total number of separations includes layoffs, retirements, and voluntary quitting. As per the latest JOLTS report, the total separations for February was 5.2 million at a rate of 3.5% of the total workforce and a decrease from the January reading of 5.9 million and 4.1%, respectively.

  • Benzingalast month

    The Size Effect Is Working With Health Care ETFs

    Investors solely focusing on large-cap health care stocks and exchange-traded funds this year are likely disappointed. Entering Tuesday, the Health Care Select Sector SPDR (NYSE: XLV), the largest ETF by assets tracking the sector, was up just 0.2 percent year-to-date. For investors willing to take on a little more risk with their health care investments, noteworthy is the fact that the size effect is working with health care stocks this year.

  • What to Expect from Johnson & Johnson’s 1Q18 Earnings
    Market Realistlast month

    What to Expect from Johnson & Johnson’s 1Q18 Earnings

    Johnson & Johnson's 1Q18 Earnings: What to Expect on April 17Johnson & Johnson’s estimates

  • MARKETS: Most investors don't expect recession in 2018
    Yahoo Finance Video9 days ago

    MARKETS: Most investors don't expect recession in 2018

    Yahoo Finance's Seana Smith speaks with Meridian Equity Partners' Jonathan Corpina about the possibility of a recession this year.

  • Health care stocks soar, did Trump just give them the all...
    CNBC Videos13 days ago

    Health care stocks soar, did Trump just give them the all...

    After Trump's announcement, are health care stocks in the clear? With CNBC's Eamon Javers, CNBC's Melissa Lee, and the Fast Money traders, Tim Seymour, David Seaburg, Brian Kelly and Steve Grasso.

  • Yahoo Finance Live: The Final Round - May 11th, 2018
    Yahoo Finance Video13 days ago

    Yahoo Finance Live: The Final Round - May 11th, 2018

    Yahoo Finance's LIVE stock market coverage and analysis.

  • Yahoo Finance Live: Midday Movers - Apr 17th, 2018
    Yahoo Finance Videolast month

    Yahoo Finance Live: Midday Movers - Apr 17th, 2018

    Yahoo Finance's LIVE stock market coverage and analysis.